Affiliation:
1. Department of Medical Microbiology and Faculty of Pharmacy, University of Manitoba, Winnipeg, Canada. ggzhanel@pcs.mb.ca
Abstract
The in vitro activities of LY-303366, a new semisynthetic echinocandin, and comparators amphotericin B, 5-fluorocytosine, fluconazole, and ketoconazole against 205 systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species were determined. LY-303366 had MICs of < or = 0.32 microg/ml for all Candida albicans (n = 99), Candida glabrata (n = 18), and Candida tropicalis (n = 10) isolates tested. LY-303366 was also active against Aspergillus species (minimum effective concentration at which 90% of the isolates are inhibited, 0.02 microg/ml) (n = 20), was less active against Candida parapsilosis (MIC at which 90% of the isolates are inhibited [MIC90], 5.12 microg/ml) (n = 10), and was inactive against C. neoformans (MIC90, >10.24 microg/ml) (n = 15) and B. dermatitidis (MIC90, 16 microg/ml) (n = 29).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference18 articles.
1. Banerjee S. N. T. G. Emori D. H. Culver R. P. Gaynes W. R. Jarvis T. Horan J. R. Edwards J. Tolson T. Henderson W. J. Henderson and W. J. Marone. 1991. Secular trends in nosocomial primary bloodstream infections in the United States 1980-1989. Am. J. Med. 91(Suppl.3B):86S-89S.
2. Current W. L. C. J. Boylan and P. P. Raab. 1993. Anti-Pneumocystis activity of LY303366 and other echinocandin B analogs abstr. 368 p. 186. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
3. The echinocandins: antifungal targets to the fungal cell wall;Debono M.;Exp. Opin. Invest. Drugs,1994
4. Friesen M. G. Harding J. Karlowsky T. Balko D. Hoban A. Kabani S. Zelenitsky M. Turik and G. G. Zhanel. 1996. Antifungal pharmacodynamic activity of the investigational echinocandin LY303366 against fluconazolesensitive (FLU-S) and fluconazole-resistant (FLU-R) Candida albicans abstr. F49 p. 108. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
5. Human mycoses: drugs and targets for emerging pathogens;Georgopapadakou N. H.;Science,1994
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献